Ingredient record · Painkiller and blood thinner
Aspirin: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
5 entries containing Aspirin are on India's banned-drugs list, and 3 are banned today. 70 batches of medicines containing Aspirin failed a government lab test between February 2019 and July 2026, from 41 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
3
Banned combinations in force
2
Other listed orders (stayed, restricted, quashed)
70
Batches failed a lab test
Jul 2026
Latest lab alert
Is it banned? Our answer pages
Not banned
On the banned-drugs list
Aspirin on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Acetyl Salicylic Acid + EthoheptazineFixed-dose combination · painkillers | Banned | S.O. 3068(E) | 11 June 2026 | 16 FDCs · Jun 2026 | Prohibited under s.26A with immediate effect, 11.06.2026 (CDSCO list published 21.07.2026). |
| Rosuvastatin 20mg + Clopidogrel 75mg + Aspirin 150mg (Gastro-Resistant) CapsuleFixed-dose combination · cardiac | Halted | CDSCO F.No. 4-01/2023-DC (Misc. 3) dated 11.04.2025, Annexure Sr. 18 | 11 April 2025 | 35 FDCs · Apr 2025 | CDSCO direction to state licensing authorities, 11 Apr 2025, not a Section 26A gazette ban |
| Rosuvastatin 10mg + Clopidogrel 75mg + Aspirin 150mg (Gastro-Resistant) CapsuleFixed-dose combination · cardiac | Halted | CDSCO F.No. 4-01/2023-DC (Misc. 3) dated 11.04.2025, Annexure Sr. 19 | 11 April 2025 | 35 FDCs · Apr 2025 | CDSCO direction to state licensing authorities, 11 Apr 2025, not a Section 26A gazette ban |
| Atorvastatin + Acetyl Salicylic Acid + CaffeineFixed-dose combination · painkillers | Banned | S.O. 184(E) | 11 January 2019 | Other orders | One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021. |
| Metoclopramide with Systemically Absorbed Drugs except Fixed Dose Combination of Metoclopramide with Aspirin/paracetamolFixed-dose combination · painkillers | Banned | GSR 603(E) | 24 August 2001 | Classic bans | Entry text as substituted vide GSR 603(E) dated 2001-08-24; original 1983/1988 notification superseded. |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Clopidogrel Aspirin | 25 | 16 | Jul 2026 |
| Aspirin Gastro Resistant | 17 | 6 | Jul 2026 |
| Aspirin | 8 | 5 | Jul 2026 |
| Rosuvastatin Aspirin Clopidogrel | 4 | 3 | May 2026 |
| Aspirin Gastro Resistant Atorvastatin | 2 | 2 | May 2026 |
| Acetylsalicylic Acid | 2 | 1 | Jul 2024 |
| Atorvastatin Aspirin | 2 | 2 | Feb 2023 |
| Acetyl Salicylic Acid | 1 | 1 | May 2026 |
| Atorvastatin Aspirin Clopidogrel S | 1 | 1 | Feb 2026 |
| Aspirin Gastro Resistance Atorvastatin | 1 | 1 | Oct 2025 |
| Opirin | 1 | 1 | Apr 2025 |
| Opirin Aspirin | 1 | 1 | Apr 2025 |
| Clorin | 1 | 1 | Jun 2023 |
| Pilogrel A | 1 | 1 | Oct 2022 |
| Rosloy Asp / | 1 | 1 | Nov 2020 |
| Delisprin | 1 | 1 | Dec 2019 |
| Clopican A | 1 | 1 | May 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Clopidogrel & Aspirin Tablets IP | P0825176TMfg 2025-08 · Exp 2027-07 | Pharmaroots HealthcareHimachal Pradesh | Dissolution, Free Salicylic Acid, Content of Clopidogrel (38.20%) and Aspirin (21.8%)Dissolution | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Clopidogrel & Aspirin Tablets | TSF-C2763Mfg 2024-10 · Exp 2026-09 | Spen Formulations Pvt. Ltd | DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Clopidogrel & Aspirin Tablets | GT31923CMfg 2026-02 · Exp 2028-01 | J.M. LaboratoriesHimachal Pradesh | Free salicylic Acid (12.01%) and Content of Aspirin (77.13%)Other | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| ASPIRIN TABLET IP 75MG | 240968Mfg 2024-09 · Exp 2027-08 | Modi AntibioticsGujarat | l]five (5) intact strips often (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2. The content of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab | Jul 2026 |
| ASPIRIN TABLET IP 75MG | 250168Mfg 2025-01 · Exp 2027-12 | Modi AntibioticsGujarat | 1. five (5) intact strips of ten (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2 The co tent of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab | Jul 2026 |
| ASPIRIN GASTRO- RESISTANT TABLETS I.P. 75 MG | CBT-0254Mfg 2025-10 · Exp 2027-09 | Crossasia Biotech Pvt. Ltd. Survery No. 488 A.B. Road Girwai industrial Area Beldarpura Gwalior 474002 (M.P) | Description test for Salicylic Acid Assay for Aspirin and test for DissolutionAssay | RDTL. Bellary KarnatakaState lab | Jul 2026 |
| Rosuvastatin, Aspirin and Clopidogrel Capsules | SIBP25509Mfg 2025-08 · Exp 2027-07 | Bioaltus Pharmaceuticals Pvt. LtdSikkim | The sample does not conform to the claim with respect to Assay of Rosuvastatin and Aspirin.Assay | DTL JaipurState lab | May 2026 |
| Clopidogrel and Aspirin Capsules | ND260242Mfg 2026-01 · Exp 2027-12 | Nanoceut Therapeutics Pvt. LtdPuducherry | Free Salicylic acidOther | DTL, Chennai-06State lab | May 2026 |
| Aspirin Gastro-resistant and Atorvastatin Capsules IP (75mg/10mg) | AAC5053Mfg 2025-07 · Exp 2027-06 | Vivimed Labs LimitedTelangana | The sample does not conforms to I.P.2022 with respect to the Test for Related substances for Aspirin and Atorvastatin.Related substances | CDTL, MumbaiCDSCO lab | May 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg | ANET1273Mfg 2024-10 · Exp 2026-09 | Unicure India LtdUttar Pradesh | Dissolution, Salicylic Acid and Assay as per IPAssay | DTL KonniState lab | May 2026 |
| Aspirin Gastro-resistant Tablets IP 75 mg | ANET1283Mfg 2024-10 · Exp 2026-09 | Unicure India LtdUttar Pradesh | Dissolution, Salicylic Acid and AssayAssay | DTL ThrissurState lab | May 2026 |
| Acetyl Salicylic Acid Tablets IP 75 mg | PFTC-23Mfg 2025-05 · Exp 2027-04 | Nestor Pharmaceuticals LimitedHaryana | Dissolution and AssayAssay | SDTL, Andhra Pradesh, VijayawadaState lab | May 2026 |
| Aspirin Gastro-Resistant Tablets IP 75mg | ANET1243Mfg 2024-05 · Exp 2026-04 | Unicure India LtdUttar Pradesh | The Sample fails the test 'Descriptive Part, Dissolution, Salicylic Acid and Assay as per IPAssay | DTL ThiruvananthapuramState lab | Apr 2026 |
| Aspirin Gastro-Resistant Tablets IP 150 mg | ASB07J24Mfg 2024-10 · Exp 2026-09 | Bajaj Healthcare LtdGujarat | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab | Mar 2026 |
| Dispersible Aspirin Tablets | T-6705Mfg 2025-07 · Exp 2027-06 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample is not of standard quality for the reason stated under Description of the tablets.Description | RDTL, GuwahatiCDSCO lab | Feb 2026 |
Showing 15 of 70 records
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.